摘要
目的:通过比较冠心病合并2型糖尿病患者冠脉介入治疗(PCI)术后选择胰岛素还是口服降糖药治疗来研究胰岛素对微循环的影响。方法:入组65例冠脉造影明确冠心病且经压力导丝测定心肌血流储备分数(FFR)<0.75的患者,植入药物支架后测量微循环阻力指数(IMR),按目前是否应用胰岛素分为联合胰岛素治疗组(胰岛素组,30例)和单纯口服降糖药治疗组(单纯降糖药组,35例),随访半年,复查IMR,比较二者对心肌微循环的影响。结果:两组的主要心血管不良事件(MACEs)发生率无明显统计学差异(P=0.07)。胰岛素组术后半年的IMR水平较单纯降糖药组显著降低[(24.5±3.1)U比(30.2±4.3)U,P<0.05]。结论:冠心病合并2型糖尿病患者介入治疗术后胰岛素治疗能显著改善心肌微循环。
Objective: To study influence of insulin on myocardial microcirculation of patients with coronary heart disease (CHD) complicated type 2 diabetes mellitus (T2DM) after percutaneous coronary intervention (PCI). Meth- ods.. A total of 65 patients, who was confirmed as CHD by coronary angiography and fractional flow reserve (FFR) d0.75 measured by pressure guidewire, were enrolled. After drug-eluting stent implantation, index of microcireula- tion resistance (IMR) was measured. According to insulin usage or not, they were divided into insulin therapy group (insulin group, n = 30) and pure oral hypoglycemic agent therapy group (pure hypoglycemic agent group, n = 35). After six-month follow up, IMR was reviewed, and IMP, was compared between two groups. Results: There was no significant difference in incidence rate of major adverse cardiovascular events (MACEs) between two groups, P= 0. 07. On six months after PCI, IMR in insulin group was significantly lower than that of pure hypoglycemic agent group [ (24.5± 3.1) U vs. (30.2± 4. 3) U, P〈O. 05]. Conclusion: Insulin therapy can improve myocardial microcirculation in patients with coronary heart disease complicated type 2 diabetes mellitus after PCI.
出处
《心血管康复医学杂志》
CAS
2015年第4期366-369,共4页
Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词
血管阻力
糖尿病
2型
冠心病
Vascular resistance
Diabetes mellitus, type 2
Coronary disease